ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2026
Triple-Action Antioxidant, Antiviral, and Immunomodulatory Effects of Hypericum perforatum Against SARS-CoV-2 Using Chemical-Based and In Vitro Methods.
Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
A critical challenge in antiviral drug development is identifying virus host interactions while ensuring reproducible clinical data on drug efficacy and safety. These limitations have renewed scientific interest in traditionally used medicinal plants to support host defense, redox balance, and immune regulation. The present study aimed to investigate the antioxidant, SARS-CoV-2 target-modulating activity, pseudovirus entry inhibition, and immunomodulatory effects of Hypericum perforatum extract (HpE) from the Mediterranean region against SARS-CoV-2 and to evaluate its potential as a plant food/nutraceutical bioactive source. The physicochemical properties of HpE were characterized using microtiter assays, HPLC, and LC-MS/MS analysis. To comprehensively determine its cellular effects, we assessed cytotoxicity using the MTT assay, morphological alterations with hematoxylin eosin staining, and examined antioxidant capacity using chemical- and cellular-based assays in Vero E6, HEK293T, Caco-2, and Calu-3 cell lines. To investigate the targeted inhibitory potential of HpE, Receptor Binding Domain (RBD)-Angiotensin Converting Enzyme 2 (ACE2) binding via ELISA and S1 pseudovirus entry in ACE2-overexpressing HEK293T cells were evaluated. Its suppression of SARS-CoV-2 main protease (Mpro) activity was examined using a Fluorescence Resonance Energy Transfer (FRET) assay. Immunomodulatory activity of HpE was investigated by ELISA. HpE exhibited robust antioxidant activity and SARS-CoV-2 relevant inhibitory effects reducing RBD-ACE2 binding by 60% and suppressing Mpro activity by 100% under the tested conditions. Additionally, HpE demonstrated selective and context-dependent immunomodulatory activity, rather than a uniform suppression of inflammatory responses. Overall, these findings indicate that HpE represents a promising plant-derived nutraceutical source for further investigation in SARS-CoV-2 relevant biological models.
Indexed as
Identifiers
42821038What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.